These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6502318

  • 1. Cloxacillin absorption and disposition in cystic fibrosis.
    Spino M, Chai RP, Isles AF, Thiessen JJ, Tesoro A, Gold R, MacLeod SM.
    J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
    [Abstract] [Full Text] [Related]

  • 2. Theophylline disposition in cystic fibrosis.
    Isles A, Spino M, Tabachnik E, Levison H, Thiessen J, MacLeod S.
    Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.
    Nauta EH, Mattie H.
    Br J Clin Pharmacol; 1975 Apr; 2(2):111-21. PubMed ID: 1234495
    [Abstract] [Full Text] [Related]

  • 4. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM, Szefler SJ, Hill MR, Jusko WJ, Larsen GL, Accurso FJ.
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum unbound levels of cloxacillin and erythromycin in cystic fibrosis.
    Valman HB, Evans KE.
    Arch Dis Child; 1970 Oct; 45(243):686-9. PubMed ID: 5477683
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug disposition in cystic fibrosis.
    Rey E, Tréluyer JM, Pons G.
    Clin Pharmacokinet; 1998 Oct; 35(4):313-29. PubMed ID: 9812180
    [Abstract] [Full Text] [Related]

  • 10. Dicloxacillin and cloxacillin: pharmacokinetics in healthy and hemodialysis subjects.
    Nauta EH, Mattie H.
    Clin Pharmacol Ther; 1976 Jul; 20(1):98-108. PubMed ID: 1277730
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, MacLeod SM.
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [Abstract] [Full Text] [Related]

  • 12. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME, Kornhauser DM.
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
    [Abstract] [Full Text] [Related]

  • 13. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J, Smith IJ, Hilman BC, Wilson JT.
    Eur J Clin Pharmacol; 1991 Mar; 40(4):333-41. PubMed ID: 2050167
    [Abstract] [Full Text] [Related]

  • 14. Rapid methylprednisolone clearance in a patient with cystic fibrosis.
    Green CG, Kraus CK, Lemanske RF, Farrell PM, Jusko WJ.
    Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253
    [Abstract] [Full Text] [Related]

  • 15. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
    Ziemniak JA, Assael BM, Padoan R, Schentag JJ.
    Eur J Clin Pharmacol; 1984 Nov; 26(2):183-9. PubMed ID: 6723756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Absorption of antibiotics in cystic fibrosis.
    Valman HB.
    Arch Dis Child; 1970 Apr; 45(240):275. PubMed ID: 5420004
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects.
    Nauta EH, Mattie H, Goslings WR.
    Chemotherapy; 1973 Apr; 19(5):261-71. PubMed ID: 4595633
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.